WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2026 Issue has been successfully launched on MAY 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

A U.S.-BASED DECENTRALIZED CLINICAL TRIAL ANALYTICS FRAMEWORK FOR ENHANCING PATIENT RECRUITMENT, RETENTION, AND DATA INTEGRITY IN HYBRID STUDY DESIGNS

Ifiala Agwu Ifiala*, Onuh Matthew Ijiga, Emmanuel Igba

ABSTRACT

Decentralized clinical trials (DCTs) have emerged as a transformative paradigm within the United States clinical research ecosystem, driven by advances in digital health technologies, regulatory flexibility, and the need to enhance patient-centricity. This review proposes a comprehensive analytics-driven framework designed to optimize patient recruitment, retention, and data integrity in hybrid clinical trial designs that integrate both decentralized and site-based elements. The study synthesizes existing literature on digital trial infrastructures, real-world data integration, and predictive analytics to construct a unified model tailored to U.S. regulatory, technological, and demographic contexts. The proposed framework emphasizes the use of advanced data analytics, including machine learning–based patient matching algorithms, real-time engagement monitoring systems, and risk-based data quality assurance mechanisms. By leveraging electronic health records (EHRs), wearable device data, and mobile health applications, the framework enables dynamic identification of eligible participants, thereby addressing persistent recruitment bottlenecks and improving population diversity. Furthermore, retention strategies are enhanced through behavioral analytics, personalized communication protocols, and adaptive intervention models that respond to patient engagement patterns in real time. A critical component of the framework is its focus on data integrity within decentralized environments. The integration of blockchain-enabled audit trails, automated anomaly detection systems, and regulatory-compliant data governance structures ensures the reliability, traceability, and security of clinical data. The review also evaluates the role of U.S. regulatory bodies, such as the FDA, in shaping guidelines for decentralized trials, emphasizing the need for standardized validation protocols and interoperability frameworks. Through a systematic examination of current methodologies and emerging technologies, this study provides a structured approach for implementing analytics-driven decentralized clinical trials. The findings highlight the potential of hybrid trial models to reduce operational costs, accelerate study timelines, and improve clinical outcomes while maintaining rigorous data quality standards. The proposed framework offers practical insights for researchers, sponsors, and policymakers seeking to advance the efficiency and inclusivity of clinical research in the evolving digital health landscape.

[Full Text Article] [Download Certificate]